Literature DB >> 2563490

Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS.

S Vento, G di Perri, R Luzzati, M Cruciani, T Garofano, C Mengoli, E Concia, D Bassetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2563490     DOI： 10.1016/s0140-6736(89)91347-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation?

Authors:  Keisuke Hino; Ashraf A Basuni; Jacqueline Ireland; Antony Newell; Jeffrey Mphahlele; Erasmus J Smit; Siew Lin Ngui; Chong Gee Teo; William F Carman
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

2.  Reactivation of hepatitis B virus in a previously immune patient with human immunodeficiency virus infection.

Authors:  B Vandercam; C Cornu; J L Gala; A Geubel; M Cahill; M E Lamy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

3.  Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance.

Authors:  Antje Knöll; Arndt Hartmann; Harald Hamoshi; Karin Weislmaier; Wolfgang Jilg
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

4.  Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.

Authors:  An Li; Quan Yuan; Zhiyin Huang; Jian Fan; Ruyi Guo; Bin Lou; Qin Zheng; Shengxiang Ge; Yixin Chen; Zhijun Su; Anthony E T Yeo; Yu Chen; Jun Zhang; Ningshao Xia
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

5.  Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1.

Authors:  E A Santos; C F T Yoshida; V C Rolla; J M Mendes; I F Vieira; J Arabe; S A Gomes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-18       Impact factor: 3.267

6.  Nucleotide sequence analysis of the precore region in patients with spontaneous reactivation of chronic hepatitis B.

Authors:  T Laskus; J Rakela; M J Tong; D H Persing
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

7.  Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection.

Authors:  T Wölfel; P Schirmacher; J Schlaak; P Knolle; H P Dienes; W Dippold; K H Meyer zum Büschenfelde; G Gerken
Journal:  Clin Investig       Date:  1994-12

8.  Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey.

Authors:  Josephine Bwogi; Fiona Braka; Issa Makumbi; Vinod Mishra; Barnabas Bakamutumaho; Miriam Nanyunja; Alex Opio; Robert Downing; Benon Biryahwaho; Rosamund F Lewis
Journal:  Afr Health Sci       Date:  2009-06       Impact factor: 0.927

9.  HBsAg may reappear following reactivation in individuals with spontaneous HBsAg seroclearance 8 years previously.

Authors:  Q Y Chen; X Y Wang; T J Harrison; X He; L P Hu; K W Li; H H Jia; Q L Yang; C Wang; Z L Fang
Journal:  Epidemiol Infect       Date:  2016-12-05       Impact factor: 4.434

10.  Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.

Authors:  Trevor G Bell; Euphodia Makondo; Neil A Martinson; Anna Kramvis
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.